1025 |
MRI Predictors of Cognitive Function After Lacunar Infarction
|
2025-05-27 |
25 |
1024 |
Extended CT angiography versus standard CT angiography for the detection of cardioaortic thrombus in patients with ischaemic stroke and transient ischaemic attack (DAYLIGHT): a prospective, randomised, open-label, blinded end-point trial
|
2025-05-27 |
38 |
1023 |
Intravenous Tenecteplase before Thrombectomy in Stroke
|
2025-05-27 |
31 |
1022 |
Effects of Intensive Blood Pressure Lowering on Brain Swelling in Thrombolyzed Acute Ischemic Stroke: The ENCHANTED Results
|
2025-04-30 |
216 |
1021 |
Optimised medical therapy alone versus optimised medical therapy plus revascularisation for asymptomatic or low-to-intermediate risk symptomatic carotid stenosis (ECST-2): 2-year interim results of a multicentre randomised trial
|
2025-04-30 |
167 |
1020 |
Acute Blood Pressure Lowering and Risk of Ischemic Lesions on MRI After Intracerebral Hemorrhage
|
2025-04-30 |
169 |
1019 |
Extended Reduced-Dose Apixaban for Cancer-Associated Venous Thromboembolism
|
2025-03-31 |
258 |
1018 |
Thrombectomy With Low ASPECTS: The Roles of Infarct Volume and Postacute Neurological Status
|
2025-03-31 |
257 |
1017 |
Optimal Duration of Dual Antiplatelet Therapy After Carotid Artery Stenting: A Nationwide Cohort Study
|
2025-03-31 |
310 |
1016 |
Early Versus Delayed Antihypertensive Treatment After Acute Ischemic Stroke by Hypertension History (CATIS-2 Trial)
|
2025-02-27 |
313 |
1015 |
Endovascular Treatment of Stroke Due to Medium-Vessel Occlusion (ESCAPE-MeVO Trial)
|
2025-02-27 |
334 |
1014 |
Endovascular Treatment for Stroke Due to Occlusion of Medium or Distal Vessels
|
2025-02-27 |
291 |
1013 |
Endovascular therapy for acute vertebrobasilar occlusion (VERITAS): a systematic review and individual patient data meta-analysis
|
2025-01-31 |
335 |
1012 |
Surgical Management of Intracerebral Hemorrhage: New Light on the Horizon?
|
2025-01-31 |
504 |
1011 |
Abelacimab versus Rivaroxaban in Patients with Atrial Fibrillation
|
2025-01-31 |
349 |